Position
Chief Executive Officer
Company
Alchemab Therapeutics
LondonBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Alchemab Therapeutics announces that Jane Osbourn, Chief Scientific Officer, has succeeded Young Kwon as Chief Executive Officer and member of the Board. Jane Osbourn has more than 30 years of biopharmaceutical industry experience and has been a key leader in the company since its inception.
Quick answer
Jane Osbourn Succeeds Young Kwon as CEO of Alchemab Therapeutics (September 12, 2024). Alchemab Therapeutics is based in London, England, United Kingdom.
- Who is the new Chief Executive Officer at Alchemab Therapeutics?
- Alchemab Therapeutics named Jane Osbourn Chief Executive Officer, announced September 12, 2024.
- What did Alchemab Therapeutics announce on September 12, 2024?
- Alchemab Therapeutics announces that Jane Osbourn, Chief Scientific Officer, has succeeded Young Kwon as Chief Executive Officer and member of the Board. Jane Osbourn has more than 30 years of biopharmaceutical industry experience and has been a key leader in the company since its inception.
- What does Alchemab Therapeutics do?
- Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.
- Where is Alchemab Therapeutics based?
- Alchemab Therapeutics is based in London, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- 89bio (September 17, 2024), Pfizer (September 5, 2024), Forward Therapeutics (September 3, 2024) and Belite Bio (September 1, 2024) also announced leadership changes within 45 days of Alchemab Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- 89bio Appoints Teresa Perney as Chief Regulatory and Quality Officer (September 17, 2024)
- Pfizer Appoints Elif Aral as Regional President for Middle East, Russia, and Africa (MERA) (September 5, 2024)
- Forward Therapeutics Appoints Ulrich Thienel, M.D., Ph.D. as Chief Medical Officer (September 3, 2024)
- Belite Bio, Inc Appoints Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer (September 1, 2024)
- Catherine Owen Adams Succeeds Steve Davis as CEO at Acadia Pharmaceuticals Inc. (September 23, 2024)
- Tagworks Pharmaceuticals BV Appoints Ken Mills as Chief Executive Officer (October 1, 2024)
Who to call at Alchemab Therapeutics, and when
A new leader at Alchemab Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Alchemab Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alchemab Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alchemab Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alchemab Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alchemab Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.